Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432–1444.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419–1431.
Rosenstein JM, Krum JM . New roles for VEGF in nervous tissue—beyond blood vessels. Exp Neurol 2004; 187: 246–253.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Case previously presented at the Edinburgh Macular Symposium, Royal College of Surgeons, Edinburgh, 5 June 2009.
Rights and permissions
About this article
Cite this article
Lyall, D., Hutchison, B., Gaskell, A. et al. Intravitreal Ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy. Eye 24, 1730–1731 (2010). https://doi.org/10.1038/eye.2010.131
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2010.131
This article is cited by
-
An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management
Journal of Ophthalmic Inflammation and Infection (2018)
-
Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis
International Ophthalmology (2018)
